OTCMKTS:ICOTF

iCo Therapeutics (ICOTF) Stock Forecast, Price & News

$0.43

0.00 (0.00%)

(As of 06/2/2023 ET)

Compare

Today's Range: $0.43
▼
$0.46
50-Day Range: $0.27
▼
$0.56
52-Week Range: $0.80
▼
$1.82

Volume: 6,086 shs
Average Volume: 4,760 shs
Market Capitalization: $3.89 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Headlines Short Interest

About iCo Therapeutics (OTCMKTS:ICOTF) Stock

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.

Receive ICOTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ICOTF Stock News Headlines

May 10, 2023 | wsj.com

ICO Group Ltd.

February 25, 2023 | marketwatch.com

Antisense & RNAi Therapeutics Market 2023 Estimated to Perceive Exponential Growth till 2028

June 2, 2023 | Behind the Markets (Ad)

[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"

The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>

February 19, 2023 | finance.yahoo.com

Women's health therapeutics market size to increase by USD 30.35 billion: North America to account for 37% of market growth - Technavio

February 19, 2023 | seekingalpha.com

Jasper Therapeutics releases promising early-stage data on sickle cell disease treatment

October 10, 2022 | usnews.com

Consumers to Ditch Cafes for Coffee at Home Amid Rising Prices, Says ICO

August 16, 2022 | investing.com

Satellos Bioscience Inc (MSCL)

June 1, 2022 | seekingalpha.com

Satellos Bioscience GAAP EPS of -C$0.06

June 2, 2023 | Behind the Markets (Ad)

[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"

December 16, 2021 | finance.yahoo.com

Satellos Bioscience Inc. Announces Scientific Research Agreement with Université de Sherbrooke to Study Rare Muscular Dystrophies

December 15, 2021 | finance.yahoo.com

Satellos Bioscience to Webcast Live at Life Sciences Investor Forum December 16th

December 9, 2021 | finance.yahoo.com

ICOTF: Targeting Stem Cells for Muscular Dystrophy Treatment

December 6, 2021 | finance.yahoo.com

Satellos Bioscience Announces New Board Appointments

December 2, 2021 | investing.com

iCo Therapeutics Inc (MSCL)

November 29, 2021 | finance.yahoo.com

Satellos Bioscience Reports Third Quarter 2021 Financial Results and Operational Highlights

October 27, 2021 | finance.yahoo.com

Satellos Bioscience Inc. Retains BND Projects Inc. for Strategic Investor Relations Services

August 5, 2021 | finance.yahoo.com

iCo Therapeutics Inc. Announces Shareholder Approval of Business Combination with Satellos Bioscience Inc.

July 15, 2021 | stockhouse.com

iCo Therapeutics Inc. V.ICO

July 9, 2021 | finance.yahoo.com

iCo Therapeutics Inc. Announces TSX Venture Exchange Conditional Approval and Provides Update Regarding Business Combination with Satellos Bioscience Inc.

June 2, 2021 | finanznachrichten.de

iCo Therapeutics Inc.: iCo Therapeutics Announces First Quarter 2021 Financial Results

May 11, 2021 | finance.yahoo.com

iCo Therapeutics Subsidiary to present Oral Amphotericin B / SARS-Cov-2 Research Results at National Pharmaceutical Sciences Meeting

April 29, 2021 | finance.yahoo.com

iCo Therapeutics Announces 2020 Year End Financial Results and Resignation of Susan Koppy

April 27, 2021 | finance.yahoo.com

iCo Therapeutics Inc. Announces Closing of Upsized Subscription Receipt Private Placement

April 23, 2021 | finance.yahoo.com

iCo Therapeutics Inc. Announces Upsized Subscription Receipt Private Placement

March 22, 2021 | finance.yahoo.com

iCo Therapeutics Inc. Agrees to a Business Combination with Satellos Bioscience Inc.

March 12, 2021 | finance.yahoo.com

iCo Therapeutics Inc. Announces Warrant Exercises

February 25, 2021 | finance.yahoo.com

IIROC Trading Halt - ICO

See More Headlines

ICOTF Price History

30 days | 90 days | 365 days | Advanced Chart

ICOTF Company Calendar

Today: 6/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:ICOTF
CUSIP: N/A
CIK: N/A
Web: www.icotherapeutics.com
Phone: (905) 336-6128
Fax: 604-602-9699
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.40)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,110,000.00
Net Margins: N/A
Pretax Margin: -4,148.78%
Return on Equity: N/A
Return on Assets: -288.85%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.72
Quick Ratio: 0.72

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.07) per share
Price / Book: -6.13

Miscellaneous

Outstanding Shares: 9,054,000
Free Float: N/A
Market Cap: $3.89 million
Optionable: Not Optionable
Beta: 2.03

Key Executives

Frank Gleeson
President & Chief Executive Officer

Warren Whitehead
Chief Financial Officer

Michael Rudnicki
Chief Scientific Officer

J. Robert Hall
Vice President-Finance & Administration

Key Competitors

View All Competitors

ICOTF Stock - Frequently Asked Questions

How have ICOTF shares performed in 2023?: iCo Therapeutics' stock was trading at $0.1716 on January 1st, 2023. Since then, ICOTF shares have increased by 150.2% and is now trading at $0.4293.
View the best growth stocks for 2023 here.
What is iCo Therapeutics' stock symbol?: iCo Therapeutics trades on the OTCMKTS under the ticker symbol "ICOTF."

How do I buy shares of iCo Therapeutics?: Shares of ICOTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is iCo Therapeutics' stock price today?: One share of ICOTF stock can currently be purchased for approximately $0.43.
How much money does iCo Therapeutics make?: iCo Therapeutics (OTCMKTS:ICOTF) has a market capitalization of $3.89 million. The biotechnology company earns $-1,110,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis.
How can I contact iCo Therapeutics?: iCo Therapeutics' mailing address is 777 Hornby Street 6th Floor, Vancouver A1, V6Z 2T3. The official website for the company is www.icotherapeutics.com. The biotechnology company can be reached via phone at (905) 336-6128, via email at liggett@icotherapeutics.com, or via fax at 604-602-9699.

This page (OTCMKTS:ICOTF) was last updated on 6/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial